SEC 13F Intelligence

Managers / Q1 2026

ADAMS STREET PARTNERS LLC

CIK 0001193586 · ONE NORTH WACKER DRIVE, STE 2700, CHICAGO, IL, 60606-2807 · 312-553-8486

Reported Value
$260M
Q1 2026
Positions
3
Filings on Record
30
2019–present window
Filed
May 15, 2026
original filing

Summary

Adams Street Partners LLC reported $260M in U.S.-listed holdings across 3 positions for Q1 2026.

The portfolio is heavily concentrated: BLLN alone accounts for 51.9% of reported value.

Compared with Q4 2025, the fund opened 0 new positions and exited 2.

Portfolio Metrics

Turnover
+8.7%
vs prior filed quarter
Largest Position
+51.9%
Billiontoone

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $477MQ4 ’18Q1 ’19: $517MQ2 ’19: $539MQ3 ’19: $500MQ4 ’19: $490MQ4 ’19Q1 ’20: $401MQ2 ’20: $484MQ3 ’20: $379MQ4 ’20: $481MQ4 ’20Q1 ’21: $624MQ2 ’21: $481MQ3 ’21: $779MQ4 ’21: $655MQ4 ’21Q1 ’22: $540MQ2 ’22: $384MQ3 ’22: $365MQ4 ’22: $300MQ4 ’22Q1 ’23: $321MQ2 ’23: $382MQ3 ’23: $286MQ4 ’23: $325MQ4 ’23Q1 ’24: $252MQ2 ’24: $243MQ3 ’24: $182MQ4 ’24: $113MQ4 ’24Q1 ’25: $113MQ2 ’25: $142MQ3 ’25: $153MQ4 ’25: $264MQ4 ’25Q1 ’26: $260Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 100.0%
  • Common Stock · 100.0% · $260M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
PAYPaymentus Holdings, Inc.SOLD OUT223.5K0$7M$0
CAICaris Life Sciences, Inc.SOLD OUT4.9K0$132,040$0
CRVSCorvus Pharmaceuticals, Inc.HELD+03.28M+$23M$48M
RMNIRimini Street, Inc.HELD+023.57M$14M$77M
BLLNBillionToOne, Inc.HELD+01.71M$5M$135M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2026

3 positions
#IssuerClass% PortfolioValueShares
1BLLNBillionToOne, Inc.history →Class A51.90%$135M1.71M
2RMNIRimini Street, Inc.history →Common29.69%$77M23.57M
3CRVSCorvus Pharmaceuticals, Inc.history →Common18.41%$48M3.28M

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$260M3May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$264M5Feb 13, 202613F-HRchanges · EDGAR ↗
Q3 2025$153M5Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$142M6Aug 13, 202513F-HRchanges · EDGAR ↗
Q1 2025$113M7May 14, 202513F-HRchanges · EDGAR ↗
Q4 2024$113M6Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$182M6Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$243M9Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$252M12May 14, 202413F-HRchanges · EDGAR ↗
Q4 2023$325M14Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$286M14Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$382M18Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$321M13May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$300M16Feb 15, 202313F-HRchanges · EDGAR ↗
Q3 2022$365M13Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$384M15Aug 17, 202213F-HRchanges · EDGAR ↗
Q1 2022$540M17May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$655M26Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$779M26Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$481M18Aug 13, 202113F-HRchanges · EDGAR ↗
Q1 2021$624M23May 10, 202113F-HRchanges · EDGAR ↗
Q4 2020$481M15Feb 11, 202113F-HRchanges · EDGAR ↗
Q3 2020$379M14Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$484M11Aug 13, 202013F-HRchanges · EDGAR ↗
Q1 2020$401M15May 14, 202013F-HRchanges · EDGAR ↗
Q4 2019$490M17Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$500M14Nov 13, 201913F-HRchanges · EDGAR ↗
Q2 2019$539M14Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$517M17May 14, 201913F-HRchanges · EDGAR ↗
Q4 2018$477M14Feb 12, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.